chr11-112094933-GC-TT
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3PP5_Moderate
The NM_003002.4(SDHD):c.443_444delGCinsTT(p.Gly148Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type MNV, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G148D) has been classified as Uncertain significance.
Frequency
Consequence
NM_003002.4 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- pheochromocytoma/paraganglioma syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- Carney-Stratakis syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- mitochondrial complex II deficiency, nuclear type 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- mitochondrial complex 2 deficiency, nuclear type 3Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- mitochondrial complex II deficiencyInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intestinal cancerInheritance: AD Classification: LIMITED Submitted by: G2P
- mitochondrial diseaseInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SDHD | NM_003002.4 | c.443_444delGCinsTT | p.Gly148Val | missense_variant | ENST00000375549.8 | NP_002993.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.443_444delGCinsTT pathogenic mutation (also known as p.G148V), located in coding exon 4 of the SDHD gene, results from an in-frame deletion of GC and insertion of TT between nucleotide positions 443 and 444. This results in the substitution of a glycine for a valine residue at codon 148, an amino acid with dissimilar properties. This variant was reported in individual(s) with features consistent with SDHD-related hereditary pheochromocytoma-paraganglioma (Ambry internal data). Other variant(s) resulting in the same amino acid change, p.Gly148Val (c.443G>T), have been identified in individual(s) with features consistent with SDHD-related hereditary pheochromocytoma-paraganglioma (Neumann et al. JAMA. 2004;292:943-951). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this variant is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at